In August, a Bengaluru health startup reportedly let go of about 350 people, roughly a third of its staff, and walked away from most of its insurance business. This week it announced $50 million to build five new hospitals. Even Healthcare has gone from "health insurance plus clinics" to something much heavier and much harder: a startup that wants to own the hospital itself.
The round, a Series B led by existing backer Khosla Ventures with Alpha Wave Global participating, was reported on 19 October by Inc42 and DealStreetAsia. It is all primary equity and takes Even's total funding past $120 million. For founders anywhere, the story is a live test of a question many startups are facing: when your first model is not working, do you double down on the second one with more capital?
Even Healthcare raised $50M (about Rs 475 crore) in a Series B led by Khosla Ventures. It plans five new hospitals in Bengaluru over six months, starting with Indiranagar, and says its valuation has tripled in 18 months.
What Even Healthcare Actually Announced
Even says the new money will fund five more hospitals in Bengaluru over the next six months, beginning with Indiranagar. It runs two multispeciality hospitals today, on Race Course Road and in HBR Layout. Inc42 reports the longer plan as one more hospital by the end of 2026 and three more by the end of FY27, with other Indian cities after that. Sources differ on the exact pace, so treat the timeline as the company's stated ambition rather than a delivered fact.
The company did not disclose an absolute valuation. It says the figure has tripled since its previous raise about 18 months ago. A Medical Dialogues report from 29 August, based on regulatory filings, had put a proposed Series B at about Rs 208 crore (roughly $22 million) at an expected valuation near $300 million. The announced $50 million is more than double that filing, so the round clearly grew; the $300 million valuation remains a press estimate, not a confirmed number.
How Even Got Here
Even was founded in 2020 by Mayank Banerjee, Matilde Giglio and Alessandro Ialongo. It started as a membership and managed care company: preventive care, consultations, diagnostics and help with insurance, sold to individuals and employers. Khosla Ventures backed it from the 2021 seed round and has stayed in every round since.
The company opened its first multispeciality hospital in Bengaluru in May 2025 and raised $20 million in January 2026, led by existing investors Lachy Groom and Alpha Wave, according to DealStreetAsia. Then came the hard part. In August, Entrackr reported, and Inc42 and Entrepreneur India followed, that Even had cut about 350 employees, around 30 to 35 percent of its workforce, while scaling back insurance. Moneycontrol put the figure at 350 to 400. Even declined to comment at the time, so the layoff number is reported, not confirmed by the company.
The Numbers
| Item | Detail |
|---|---|
| Round | $50M Series B (about Rs 475 crore), all primary equity |
| Lead investor | Khosla Ventures, with Alpha Wave Global |
| Total funding | More than $120M |
| Valuation | Not disclosed; company says it tripled in 18 months (press estimate near $300M) |
| Hospitals today | 2 in Bengaluru (Race Course Road, HBR Layout) |
| Planned | 5 new Bengaluru hospitals within 6 months, per DealStreetAsia |
| Members | More than 2.5 lakh (250,000) across 10 cities, company claim |
| Re-admissions | Below 1% in insurance partner programmes, company claim |
| Reported layoffs | About 350 people, 30 to 35% of staff (August, unconfirmed by Even) |
The Bet: Salaried Doctors and Fewer Hospital Stays
Even's pitch is that most of the waste in Indian private healthcare comes from incentives. In a typical fee-for-service hospital, more procedures mean more revenue. Even says its doctors are salaried, with pay not tied to procedures or revenue, and that it runs preventive care, outpatient visits, diagnostics, hospitalisation and recovery as one connected service.
The company backs this with figures it supplied to the press. It says unplanned re-admissions in its insurance partner programmes are below 1 percent, against an industry range of 8 to 15 percent, and that average hospital stays are 40 percent shorter. It also says more than 200 members avoided hospitalisation, saving an estimated Rs 15 to 16 crore, and that 85 to 90 percent of members near its hospitals choose Even for their care. None of these has been independently audited, and the company reports that its two Bengaluru hospitals reached profitability "in record time" without publishing margins.
That last point matters. Even has not released revenue or loss figures with this round, so the investment case rests on unit economics we cannot yet check. A hospital is also a capital-heavy asset: buildings, equipment, specialist hiring and months of ramp-up before a new site pays back.
Why It Matters Beyond India
India is one of the largest healthcare markets where out-of-pocket spending still dominates and quality varies sharply between hospitals. A model that aligns doctor pay with patient outcomes, if it holds at scale, would be copied. The same tension exists in the US and UK, where value-based care and capitated models keep running into the realities of building physical clinics.
It is also part of a pattern GizPulse has been tracking in this section. In M-KOPA's purchase of KilpiTek, covered in [our report on the deal](/blog/m-kopa-buys-kilpitek-8-million-device-locking), a fintech decided to own a critical piece of infrastructure rather than rent it. Even is making a similar move in health: owning the hospital instead of sitting between patients and someone else's hospital.
READ ALSO: M-KOPA Buys KilpiTek for $8M to Own the Lock Behind Its Loans
READ ALSO: YoLa Fresh Shuts Down: Why Morocco's $9M Agritech Startup Failed
Lessons for Founders
- A pivot is not a failure if you fund the second model fully. Even cut costs, narrowed its focus and then raised more than twice what filings first suggested. Investors backed the sharper story.
- Cut early, explain clearly. Layoffs that arrive with a clear strategic reason are easier for investors to forgive than slow bleeding. Silence, as Even chose in August, leaves the story to others.
- Publish your unit economics. Claims such as sub 1 percent re-admissions are strong, but they invite scrutiny. Founders who release audited margins earlier win trust faster.
- Capital intensity changes everything. A software company can fix a mistake with a deploy. A hospital cannot. Plan for slower learning cycles and larger cheques.
- Loyal early investors are an asset. Khosla Ventures led the Series B after funding the seed. Existing backers who have seen the model up close are often the first to double down.
What to Watch Next
- Whether the Indiranagar hospital opens on schedule, and how fast the next four follow.
- Whether Even publishes revenue, losses or hospital level margins in its next filings.
- Whether the readmission and stay length claims survive outside its own members and partners.
- Whether competitors in Indian managed care copy the salaried doctor model or fight it.
Frequently Asked Questions
How much did Even Healthcare raise and who led the round?
Even Healthcare raised $50 million (about Rs 475 crore) in a Series B led by existing investor Khosla Ventures, with participation from Alpha Wave Global, according to reports published on 19 October 2026. Total funding now exceeds $120 million.
What is Even Healthcare's business model?
Even runs hospitals and managed care for members in Bengaluru and says it covers preventive care, consultations, diagnostics, insurance access, hospitalisation and recovery. Its doctors are salaried and not paid per procedure, a design the company says reduces unnecessary treatment.
Did Even Healthcare lay off employees?
Outlets including Inc42 and Entrepreneur India reported in August 2026 that Even cut about 350 employees, roughly 30 to 35 percent of its workforce, while shifting from insurance to a hospital led model. Even did not confirm the figures.
What is Even Healthcare's valuation?
The company has not disclosed it. It says valuation tripled in 18 months. An earlier Medical Dialogues report based on filings estimated about $300 million, which is unconfirmed.
